CLINICAL_TRIALS
trial_result
· 2014-01-08
Clinical Trial Update: A Study of OPC-262 in Patients With Type 2 Diabetes [Phase 3]
Summary
A Phase 3 study of OPC-262 in patients with Type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED